WO2003026508A1 - Echographe - Google Patents

Echographe Download PDF

Info

Publication number
WO2003026508A1
WO2003026508A1 PCT/JP2002/000945 JP0200945W WO03026508A1 WO 2003026508 A1 WO2003026508 A1 WO 2003026508A1 JP 0200945 W JP0200945 W JP 0200945W WO 03026508 A1 WO03026508 A1 WO 03026508A1
Authority
WO
WIPO (PCT)
Prior art keywords
ultrasonic
waveform
sound pressure
wave
diagnostic apparatus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/000945
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
Shin-Ichiro Umemura
Ken-Ichi Kawabata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi Healthcare Manufacturing Ltd
Original Assignee
Hitachi Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Medical Corp filed Critical Hitachi Medical Corp
Priority to US10/466,630 priority Critical patent/US7278968B2/en
Publication of WO2003026508A1 publication Critical patent/WO2003026508A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48Diagnostic techniques
    • A61B8/481Diagnostic techniques involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01SRADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
    • G01S15/00Systems using the reflection or reradiation of acoustic waves, e.g. sonar systems
    • G01S15/88Sonar systems specially adapted for specific applications
    • G01S15/89Sonar systems specially adapted for specific applications for mapping or imaging
    • G01S15/8906Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques
    • G01S15/895Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques characterised by the transmitted frequency spectrum

Definitions

  • the present invention relates to an ultrasonic diagnostic apparatus for imaging the inside of a subject such as a living body by transmitting and receiving ultrasonic waves.
  • Ultrasonic diagnostic apparatuses that transmit and receive pulsed ultrasonic waves to a living body and image the inside thereof are widely used for medical diagnosis.
  • imaging modalities in the field of X-rays and MRI, contrast agents have been used for imaging of the circulatory system.
  • contrast agents have not been widely used in ultrasonic diagnostics until now, but in recent years, a formulation in which microbubbles having a size on the order of microns * have been stabilized in some way. With the advent of contrast agents, the method has been widely used. This principle utilizes the fact that microbubbles with a diameter of about 1 micron resonate with the ultrasonic waves of several MHz used in ultrasonic diagnostics and vibrate with large amplitudes. The reflection produces a contrast ability.
  • X-ray and MRI contrast agents do not irreversibly change their physical properties due to the effects of electromagnetic waves applied for imaging or applied magnetic fields.
  • the contrast agent of the stabilized micropable preparation system may be disintegrated and disappeared by the irradiation of the ultrasonic waves irradiated for imaging, and the contrast ability may be greatly reduced. This is due to the fact that under stable imaging conditions, the image is irradiated with ultrasonic waves of sufficient intensity and frequency to obtain a good image SN ratio. It becomes a problem when trying.
  • the contrast agent in the region of interest can be appropriately erased and the contrast conditions can be initialized.
  • This can be considered to be a unique feature of the stabilized contrastable mic orifice-based ultrasound contrast agent that is significantly different from X-ray and MRI contrast agents.
  • the most widely used and simplest measure of ultrasonic intensity is the ultrasonic energy per premature time, commonly called the ultrasonic intensity.
  • MI maximum negative pressure
  • no square root of the center frequency
  • the intensity and irradiation frequency of the ultrasonic waves represented by these indices are low during a time phase in which it is not desired to decrease the density of the contrast agent in the subject, for example, the region of the living body to be examined.
  • a mode is provided to capture images by irradiating ultrasonic waves at a low level.
  • it is difficult to obtain a good image S / N ratio due to insufficient ultrasonic signal strength, and the imaging rate decreases at low ultrasonic irradiation frequency, and the change of the target body region on the ultrasonic image There is a problem that it cannot be followed sufficiently.
  • the present invention firstly aims to stabilize a micro-pulverized body region of interest while irradiating ultrasonic energy necessary for obtaining a good image SN ratio and a sufficient frame rate. Second, it is possible to suppress the decrease in the density of the system contrast agent, and, if necessary, stabilize the microvapour contrast agent in the region of interest while controlling the ultrasonic intensity and mechanical index within the safety limits. It is an object of the present invention to provide an ultrasonic diagnostic apparatus that can be efficiently eliminated.
  • the maximum negative pressure emphasized waveform that emphasizes the maximum amplitude negative pressure peak value that is, the maximum negative pressure emphasized waveform that is larger than the positive pressure side peak value (Fig. 6)
  • the ultrasonic sound The sound pressure rise emphasis waveform whose waveform rises more steeply than its fall (Fig. 7, also called N-wave), and the sound pressure fall emphasis waveform whose fall of the ultrasonic sound pressure waveform steeper than its rise (Fig. 8 , And also called inverse N-wave).
  • Figure 1 shows the results of theoretically predicting the behavior of a microbubble exposed to the sound pressure of such a waveform by numerical calculation, and comparing the total ultrasonic energy of the fundamental wave and the second harmonic with the same.
  • the thick solid line indicates the case of the maximum positive pressure emphasized waveform
  • the thick dotted line indicates the case of the maximum negative pressure emphasized waveform
  • the thin solid line indicates the case of the sound pressure rise emphasized waveform
  • the thin dotted line indicates the case of the sound pressure fall emphasized waveform.
  • the sound pressure drop emphasis waveform maximizes the maximum surface area during microbubble vibration, and conversely, in the region where the ultrasonic intensity is relatively low, the sound pressure rise emphasis waveform or the maximum positive It was found that the pressure emphasis waveform minimized the maximum surface area during vibration.
  • Figure 2 shows the results of a comparison of the maximum surface area during microbubble vibration for each waveform with a common mechanical index.
  • the thick solid line, the thick dotted line, the thin solid line, and the thin dotted line in the figure are the same as in FIG.
  • the maximum surface area during vibration was the maximum at the time of the maximum positive pressure emphasis waveform. Therefore, it is considered that the maximum positive pressure emphasized waveform is suitable for efficiently eliminating the stabilized microbubble-based contrast agent in the target living body region under the condition of a constant mechanical index.
  • the present invention is suitable for suppressing the decrease in the density of the stabilized micro-purple contrast agent in the region of interest by superimposing the harmonics on the fundamental wave and controlling the order correlation between the two.
  • the problem is solved by creating a waveform that has been reduced or, conversely, a waveform that is suitable for efficient reduction, and using the waveform appropriately as needed.
  • the ultrasonic diagnostic apparatus of the present invention uses the ultrasonic probe to transmit and receive ultrasonic waves to and from the object to which the contrast agent has been introduced, thereby imaging the inside of the object to be inspected.
  • the ultrasonic probe is configured to transmit an ultrasonic pulse in which a fundamental wave and a harmonic including at least a second harmonic of the fundamental wave are superimposed. It is characterized by
  • the present invention is characterized in that, in the above configuration, the ultrasonic pulse transmitted from the ultrasonic probe includes a sound pressure drop emphasis waveform in which the fall of the ultrasonic waveform is sharper than the rise.
  • the ultrasonic wave transmitted from the probe is characterized in that it comprises a maximum positive pressure emphasis waveform in which the maximum amplitude positive pressure side peak value is greater than the negative pressure side peak value.
  • the present invention is characterized in that, in the above configuration, the sound pressure drop emphasizing waveform and the maximum positive pressure emphasizing waveform are switchable according to a transmission mode.
  • the present invention is characterized in that, in the above configuration, an ultrasonic image captured using an ultrasonic pulse having the sound pressure drop emphasizing waveform or the maximum positive pressure emphasizing waveform is displayed.
  • the present invention is characterized in that, in the above configuration, the contrast agent contains micro purple, and a center frequency of the fundamental wave is set in accordance with a resonance frequency of the micro purple.
  • the ultrasonic pulse may have a waveform in which the fundamental wave and a 2nd harmonic having a phase shifted by ⁇ / 2 at the zero cross point of the fundamental wave are superimposed. It is characterized by.
  • the invention is characterized in that, in the above configuration, the ultrasonic pulse has a waveform in which the fundamental wave and the fundamental wave are superimposed with a double harmonic having the same phase at a zero cross point thereof. I do.
  • a maximum positive pressure emphasized waveform in which a maximum amplitude positive sound pressure side peak value is larger than a negative sound pressure side peak value, and a maximum amplitude negative sound pressure side peak value is a positive sound pressure side
  • the present invention in the above configuration, transmits an ultrasonic pulse wave having the sound pressure rise emphasis waveform or the maximum positive pressure emphasis waveform as a main component. And a second mode for transmitting an ultrasonic pulse wave having the sound pressure drop emphasizing waveform or the maximum positive pressure emphasizing waveform as a main component.
  • FIG. 1 shows the maximum surface area during microbubble vibration comparing the total ultrasonic energy of the fundamental wave and the second harmonic wave as a common one.
  • Fig. 2 shows the maximum surface area during microbubble vibration comparing the same mechanical index.
  • FIG. 3 is a block diagram illustrating a configuration of one embodiment of the present invention
  • FIG. 4 is a block diagram illustrating a configuration of another embodiment of the present invention
  • FIG. 5 is a block diagram illustrating the configuration of another embodiment of the present invention.
  • Fig. 6 shows the transmitted sound pressure waveform (1) measured by a needle-shaped hydrophone immediately adjacent to the probe of the ultrasonic diagnostic apparatus.
  • Fig. 6 shows the waveform measured by the needle-shaped hydrophone immediately adjacent to the probe of the ultrasonic diagnostic apparatus of the present invention.
  • FIG. 1 shows the maximum surface area during microbubble vibration comparing the total ultrasonic energy of the fundamental wave and the second harmonic wave as a common one.
  • Fig. 2 shows the maximum surface area during microbubble vibration comparing the same
  • FIG. 7 is a diagram showing a transmitted sound pressure waveform (2)
  • FIG. 7 is a diagram showing a transmitted sound pressure waveform (3) measured by a needle-type microphone near the probe of the ultrasonic diagnostic apparatus of the present invention.
  • the probe of the ultrasonic diagnostic apparatus of the present invention Fig. 9 shows the transmitted sound pressure waveform (4) measured by a needle-shaped hydrophone in Fig. 9, and Fig. 9 shows the results of measurement of the particle size distribution of the stabilized microphone mouth purple before and after ultrasonic irradiation by the ultrasonic diagnostic apparatus of the present invention
  • FIG. 10 shows the results of measurement of the particle size distribution of stabilized microbubbles before and after ultrasonic irradiation by the ultrasonic diagnostic apparatus of the present invention (2)
  • FIG. 10 shows the results of measurement of the particle size distribution of stabilized microbubbles before and after ultrasonic irradiation by the ultrasonic diagnostic apparatus of the present invention (2)
  • FIG. 10 shows the results of measurement of the particle size distribution of stabilized microbubble
  • FIG. 11 shows the results of the present invention.
  • Figure 3 shows the results of measurement of the particle size distribution of stabilized microbubbles before and after ultrasonic irradiation by the ultrasonic diagnostic apparatus of Fig. 1.
  • Fig. 12 shows the stability before and after ultrasonic irradiation by the ultrasonic diagnostic apparatus of the present invention.
  • Fig. 4 shows the results of measurement of particle size distribution (4) of a micro-bubble.
  • 3 and 4 are block diagrams showing a typical configuration of an apparatus in which the present invention is applied to an ultrasonic diagnostic apparatus based on a pulse echo method.
  • the transmission waveform control unit 1 emphasizes the positive peak pressure value of the maximum amplitude, that is, the maximum positive pressure emphasized waveform that is larger than the negative sound pressure peak value, such as the sound pressure waveforms shown in FIGS. 5 to 8 as examples.
  • the maximum negative pressure emphasis waveform in which the peak value of the maximum amplitude negative sound pressure side is emphasized that is, larger than the positive sound pressure side peak value
  • the rising of the ultrasonic sound pressure waveform is steeper than the falling
  • the directional ultrasonic pulse sent out from the transducer array 5 to the living body in this way is reflected by living tissue and a contrast agent, and a part of the pulse returns to the transducer array 5, and each of the constituent elements Is received.
  • each signal of the element selected by the element selection switch 4 is amplified by the preamplifier 6, then subjected to AZD conversion, and temporarily stored in the reception memory 7.
  • the A / D conversion is generally performed. This is because ultrasonic waves propagating in the living body Compensating that the amplitude of the received signal decreases almost in proportion to the elapsed time from the transmission corresponding to the attenuation in proportion to the seeding distance, the signal amplitude at the entrance of the A / D converter is compensated. This is a process to keep the size within a certain range. This prevents a reduction in signal dynamic range due to amplitude quantization in A / D conversion.
  • by passing the signal through a band-limiting filter before the A / D conversion it is possible to prevent aliasing due to time axis quantization in the A / D conversion.
  • the reception signal of each element stored in the memory 7 is given a kind of delay according to the position of each element and then added to each other to obtain a convergence effect.
  • the reception convergence delay adding section 8 performs the processing.
  • the optimum value of the delay time to be given to the signal of each element changes according to the focal length of the receiving wave.
  • the optimum value of the focal length of the receiving wave for obtaining a good pulse echo image becomes longer in proportion to the elapsed time from the transmission and the speed of sound. Therefore, it is desirable to use a receiving method in which the delay time given to the signal of each element is changed according to the elapsed time from the transmission. In this method, as shown in FIG. 3 and FIG.
  • a nonlinear component is extracted from the signal obtained by delay addition for convergence of the received wave, and this component is extracted. A similar process is performed to obtain a display signal. As a result, it is possible to obtain a Panoles echo image in which the distribution of the stabilized micro-bubble contrast agent having a large non-linear reflectivity as compared with the biological tissue is emphasized.
  • a harmonic generated by a non-linear effect is separated and extracted from a fundamental wave by a band-pass filter.
  • a basic method of forming a nonlinear component with the harmonic component separated by the band-pass filter is used. It cannot be used as is.
  • Non-linear component extraction methods that do not depend on bandpass filters include a pulse inversion method and an amplitude modulation method.
  • FIG. 3 shows an embodiment of the present invention when these are applied.
  • a sound pressure waveform in which a -harmonic is superimposed on a fundamental wave as shown in Figs. 5 to 8 as an example is selected, and the amplitude is changed in a plurality of ways and transmitted.
  • the principle of the nonlinear component extraction is that the amplitude of the received echo linear component is proportional to the transmission amplitude, but the amplitude of the nonlinear component is not proportional to the transmission amplitude.
  • the signal after reception convergence obtained by transmitting at the first amplitude A1 is recorded in the memory 9 and the second amplitude A2 is used.
  • the signal after the convergence of the signal obtained by transmitting the signal is multiplied by A1 to A2, and the difference from the signal recorded in the memory 9 is taken to eliminate the linear component and extract the nonlinear component.
  • a 1 and A 2 are positive real numbers.
  • the pulse inversion method uses a pair of real numbers with inverted signs and the same absolute value as A 1 and A 2.
  • a waveform that emphasizes the maximum positive pressure and a waveform that emphasizes the maximum negative pressure, a waveform that emphasizes the sound pressure rise, and a waveform that emphasizes the sound pressure fall are: like this 2/00945
  • microbubble contrast agents are susceptible to irreversible changes such as instability, loss, contraction, and association due to irradiation with ultrasonic pulses.
  • FIG. 4 shows another embodiment of the present invention in the case of obtaining a pulse echo image in which the distribution of the contrast agent is enhanced by utilizing such properties.
  • One of the sound pressure waveforms in which the harmonics are superimposed on the fundamental wave as shown in Figs. 5 to 8 as an example is selected and transmitted with a constant amplitude multiple times.
  • the signal after reception convergence obtained by the first transmission is recorded in the memory 9 and the signal after reception convergence obtained by the second transmission is recorded.
  • the component that does not change is eliminated, and the fluctuation component corresponding to the irreversible change of the contrast agent is extracted.
  • the signal of the stationary biological tissue is completely erased, which may be inconvenient in displaying the distribution position of the contrast agent.
  • the weight given to the signal obtained by the first transmission and the weight given to the signal obtained by the second transmission are not completely equal to 1: 1, but rather increased by several% or Decreased Can be dealt with.
  • the time axes instead of making the time axes completely coincide when taking the difference, it is possible to deal with this by shifting the ultrasonic cycle by several%.
  • the signal obtained by performing such signal processing in the fluctuation component extraction unit 11 is subjected to the processing described in the previous section to obtain a display signal.
  • FIGS. 5 to 8 show transmission sound pressure waveforms when an ultrasonic wave is irradiated into water using the ultrasonic diagnostic apparatus of the embodiment of the present invention having the configuration of FIG. 3 or FIG.
  • the results obtained by using a needle-shaped hydrophone near the probe are shown.
  • a hydrophone capable of obtaining a voltage pressure having the same sign as the input sound pressure was used.
  • the four types of sound pressure waveforms obtained by shifting the phase relationship are the maximum positive pressure emphasis waveform in Fig. 5 and the maximum negative pressure waveform in Fig. 6.
  • the emphasized waveform, the sound pressure rise emphasized waveform (N wave) in Fig. 7, and the sound pressure fall emphasized waveform (inverse N wave) in Fig. 8 are shown.
  • the amplitudes of the fundamental wave component and the second harmonic wave component were fixed.
  • Figures 9 to 12 show the size of microbubbles before and after irradiating ultrasonic waves with the sound pressure waveforms shown in Figures 5 to 8 into water and irradiating microbubbles suspended in water a certain number of times. The results of examining the change in the distribution of (particle size) are shown.
  • Figures 9 to 12 show the maximum positive pressure emphasis waveform (Fig. 5), maximum negative pressure emphasis waveform (Fig. 6), sound pressure rise emphasis waveform (Fig. 7), and sound pressure fall emphasis as sound pressure waveforms, respectively. The case where the waveform (Fig. 8) is used is shown.
  • the solid line (B) shows the difference before and after the ultrasonic irradiation
  • the dashed line (C) shows the difference before and after the ultrasonic irradiation
  • the dashed line (D) shows the difference between the results before and after the ultrasonic irradiation.
  • the number of microbubbles with a diameter of less than 1 micron has increased slightly. It is considered that the stabilized shell was counted.
  • the sound pressure rise emphasis waveform, the maximum positive pressure emphasis waveform, or a waveform in between them is selected, and the fluctuation due to multiple transmissions is selected. It is advantageous to obtain a pulse echo image in which the distribution of the contrast agent is enhanced by component extraction or nonlinear component extraction by the amplitude modulation method.
  • the present invention by controlling the transmission waveform, it is possible to suppress a decrease in the density of the stabilized micro-purple contrast agent in the target living body region while suppressing a decrease in the density of the favorable image SN ratio and the sufficient frame rate.
  • Ultrasonic imaging is possible, and the ultrasound intensity and mechanical index are kept within safety limits, and the stabilizing microphone area of the target biological area is efficiently eliminated as needed, while the bubble-based contrast agent is efficiently used.

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Remote Sensing (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radar, Positioning & Navigation (AREA)
  • Acoustics & Sound (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • General Physics & Mathematics (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
PCT/JP2002/000945 2001-09-20 2002-02-06 Echographe Ceased WO2003026508A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/466,630 US7278968B2 (en) 2001-09-20 2002-02-06 Ultrasonograph

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001286315A JP4157688B2 (ja) 2001-09-20 2001-09-20 超音波診断装置
JP2001-286315 2001-09-20

Publications (1)

Publication Number Publication Date
WO2003026508A1 true WO2003026508A1 (fr) 2003-04-03

Family

ID=19109324

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/000945 Ceased WO2003026508A1 (fr) 2001-09-20 2002-02-06 Echographe

Country Status (3)

Country Link
US (1) US7278968B2 (enExample)
JP (1) JP4157688B2 (enExample)
WO (1) WO2003026508A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010127546A1 (zh) * 2009-05-07 2010-11-11 Liu Zheng 微泡在制备用于联合超声产生高强度空化作为抗肿瘤新生血管药物的用途

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040230121A1 (en) * 2003-02-20 2004-11-18 Rune Hansen Ultrasonic contrast agent imaging by dualband pulse transmission
US20050273010A1 (en) * 2004-06-02 2005-12-08 Shi William T Method and system for ultrasound contrast-imaging
US20110028835A1 (en) * 2008-04-04 2011-02-03 Kenichi Kawabata Ultrasonic wave irradiation device
JP5490609B2 (ja) * 2010-05-13 2014-05-14 日立アロカメディカル株式会社 超音波診断装置
JP5510087B2 (ja) * 2010-06-08 2014-06-04 コニカミノルタ株式会社 超音波診断装置
US11730452B2 (en) 2019-04-09 2023-08-22 Insightec Ltd. Systems and methods for regulating microbubbles in ultrasound procedures

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08196537A (ja) * 1995-01-31 1996-08-06 Toshiba Corp 超音波診断装置
JPH09131344A (ja) * 1995-11-10 1997-05-20 Ge Yokogawa Medical Syst Ltd 超音波撮像方法および装置並びに超音波探触子および超音波造影剤
JPH09164138A (ja) * 1995-10-10 1997-06-24 Advanced Technol Lab Inc コントラスト剤を使用した超音波診断画像処理方法および該診断装置
JPH1028685A (ja) * 1996-07-18 1998-02-03 Ge Yokogawa Medical Syst Ltd 超音波イメージング方法及び装置並びに超音波造影剤及びその製造方法
WO1999017808A1 (en) * 1997-10-03 1999-04-15 University Of Virginia Ultrasound bubble recognition imaging
JPH11244284A (ja) * 1998-03-05 1999-09-14 Ge Yokogawa Medical Systems Ltd 超音波撮像方法および装置
EP1126287A2 (en) * 2000-02-17 2001-08-22 Aloka Co. Ltd. Ultrasonic diagnosis apparatus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331692T2 (de) * 1992-09-16 2002-10-24 Hitachi, Ltd. Ultraschallbestrahlungsgeraet
US5558092A (en) * 1995-06-06 1996-09-24 Imarx Pharmaceutical Corp. Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously
US6110120A (en) * 1997-04-11 2000-08-29 Acuson Corporation Gated ultrasound imaging apparatus and method
US6312379B1 (en) * 1997-08-15 2001-11-06 Acuson Corporation Ultrasonic harmonic imaging system and method using waveform pre-distortion
US6398735B1 (en) * 2000-03-07 2002-06-04 Koninklijke Philips Electronics N.V. Detecting a relative level of an ultrasound imaging contrast agent
JP4642977B2 (ja) * 2000-07-26 2011-03-02 株式会社東芝 超音波診断装置及び超音波イメージング方法
US6656123B2 (en) * 2001-12-19 2003-12-02 Koninklijke Philips Electronics N.V. Combined fundamental and harmonic ultrasonic imaging at low MI or deeper depths

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08196537A (ja) * 1995-01-31 1996-08-06 Toshiba Corp 超音波診断装置
JPH09164138A (ja) * 1995-10-10 1997-06-24 Advanced Technol Lab Inc コントラスト剤を使用した超音波診断画像処理方法および該診断装置
JPH09131344A (ja) * 1995-11-10 1997-05-20 Ge Yokogawa Medical Syst Ltd 超音波撮像方法および装置並びに超音波探触子および超音波造影剤
JPH1028685A (ja) * 1996-07-18 1998-02-03 Ge Yokogawa Medical Syst Ltd 超音波イメージング方法及び装置並びに超音波造影剤及びその製造方法
WO1999017808A1 (en) * 1997-10-03 1999-04-15 University Of Virginia Ultrasound bubble recognition imaging
JPH11244284A (ja) * 1998-03-05 1999-09-14 Ge Yokogawa Medical Systems Ltd 超音波撮像方法および装置
EP1126287A2 (en) * 2000-02-17 2001-08-22 Aloka Co. Ltd. Ultrasonic diagnosis apparatus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KEN-ICHI KAWABATA AND SHIN-ICHIRO UMEMURA: "Study of efficient sonochemical reaction by focused ultrasound", IEEE ULTRASONICS SYMPOSIUM, vol. 84, 1992, pages 1281 - 1285, XP010103642 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010127546A1 (zh) * 2009-05-07 2010-11-11 Liu Zheng 微泡在制备用于联合超声产生高强度空化作为抗肿瘤新生血管药物的用途

Also Published As

Publication number Publication date
US7278968B2 (en) 2007-10-09
JP4157688B2 (ja) 2008-10-01
US20040152985A1 (en) 2004-08-05
JP2003088520A (ja) 2003-03-25

Similar Documents

Publication Publication Date Title
US11350909B2 (en) Cross amplitude modulation ultrasound pulse sequence
JP4022393B2 (ja) 超音波診断装置
JP5322522B2 (ja) 超音波診断装置
JP2005523743A (ja) 造影剤強化カラーフロー描出処理
JP5154554B2 (ja) 非線形イメージングのためのパルスインバージョンシーケンス
Sun et al. High-frequency dynamics of ultrasound contrast agents
KR20050058365A (ko) 개선된 고조파 영상 처리를 위한 시스템 및 방법
JP2002542869A (ja) 造影剤を用いた灌流の実時間超音波映像法
Biagi et al. Stable and transient subharmonic emissions from isolated contrast agent microbubbles
JP4607528B2 (ja) 超音波診断装置及び画像データ生成方法
JP4157688B2 (ja) 超音波診断装置
Xu et al. High-frequency ultrasound Doppler system for biomedical applications with a 30-MHz linear array
Hauff et al. Ultrasound basics
Borsboom et al. Pulse subtraction time delay imaging method for ultrasound contrast agent detection
Kirkhorn et al. Three-stage approach to ultrasound contrast detection
Lin et al. Ultrasound contrast imaging: influence of scatterer motion in multi-pulse techniques
Palanchon et al. New technique for emboli detection and discrimination based on nonlinear characteristics of gas bubbles
Li et al. An integrated system for superharmonic contrast-enhanced ultrasound imaging: Design and intravascular phantom imaging study
Van der Steen et al. Harmonic imaging at high frequencies for IVUS
Wells Ultrasound imaging
JP5186155B2 (ja) 超音波診断装置
JPH1085211A (ja) 超音波撮像方法および装置
Vos et al. Parametric array technique for microbubble excitation
Chang et al. Second harmonic imaging and harmonic Doppler measurements with Albunex
JP2010268945A (ja) 超音波診断装置

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10466630

Country of ref document: US

122 Ep: pct application non-entry in european phase